Hoth Therapeutics Inc (HOTH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access HOTH Annual Cash Flow →
The data below summarizes Hoth Therapeutics Inc's cash flow activity from Jun 30 2025 to Jun 30 2026, enabling a period-by-period view of cash movement.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-6.53
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.30
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized0.00
Research And Developmentlicenses Acquired Expensed-
Change In Fair Value Of Investment In Joint Venture-
Research And Developmentacquired Patent Expensed0.03
Income taxes0.00
Marketable Securities, Unrealized Gain (Loss), Excluding Other than Temporary Impairments, Total0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities-0.06
Increase (Decrease) in Other Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.15
Other Working Capital0.00
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.88
Discontinued operations0.00
Net Cash flow from Operating Activities-6.02
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Sale Of Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.15
Discontinued operations0.00
Net Cash Flow from Investing Activities0.15
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock5.85
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net1.67
Proceeds From Issuance Of Series Convertible Preferred Stock And Warrants For Cash In Offering Net-
Proceeds From Issuance Of Notes Payable Related Party-
Repayment Of Notes Payable Related Party-
Nominal Amount Paid For Shares By Employees And Nonemployees-
Repurchase Of Restricted Stock Units To Pay For Employee Withholding Taxes-
Proceeds From Issuance Of Common Stock And Warrants-
Payment Of Employee Withholdings For Vested Restricted Stock-
Proceed From Issuance Common Stock Common Stock Warrants And Prefunded Warrants Net Of O-
Proceeds From Issuance Common Stock Net Of Offering Cost-
Proceeds From Issuance Common Stock Common Stock Warrants And Prefunded Warrants Net-
Proceeds From Issuance Of Common Stock Common Stock Warrants And Prefunded Warrants Net Of Offering Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.52
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-6.02
Total Cash Flow1.64
4 historic quarters locked

Sign in to unlock the full Hoth Therapeutics Inc cash flow history.

About Rocket One Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-090048

Figures are derived from filed reports and may be restated. Historical data is subject to revision.